Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy Studies.
Journal: Molecular cancer therapeutics
Published: January 06, 2026
Bimodal genomic approach predicting Semaphorin 7A (SEMA7A) as prognostic biomarker in adrenocortical carcinoma.
Journal: bioRxiv : the preprint server for biology
Published: April 28, 2025
Epigenetic priming promotes tyrosine kinase inhibitor resistance and oncogene amplification.
Journal: Nature structural & molecular biology
Published: March 31, 2025
Local Ablative Therapy Followed by Osimertinib Rechallenge in Oligoprogressive, EGFR-Mutated NSCLC: A Phase 2 Study.
Journal: JTO clinical and research reports
Published: February 26, 2025
Epigenetic priming promotes acquisition of tyrosine kinase inhibitor resistance and oncogene amplification in human lung cancer.
Journal: bioRxiv : the preprint server for biology
Published: February 20, 2025
Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma.
Journal: Nature communications
Published: October 22, 2024
Identification of DLK1, a Notch ligand, as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma.
Journal: bioRxiv : the preprint server for biology
Published: October 17, 2024
NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING.
Journal: The Journal of clinical investigation
Published: August 01, 2024
Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer.
Journal: EMBO molecular medicine
Published: February 17, 2024
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient Samples.
Journal: Cancer research communications
Published: February 14, 2024
Staufen1 Represses the FOXA1-Regulated Transcriptome by Destabilizing FOXA1 mRNA in Colorectal Cancer Cells.
Journal: Molecular and cellular biology
Published: February 13, 2024
Last Updated: 09/26/2026